60 Degrees Pharmaceuticals Inc
NASDAQ:SXTP
Cash Flow Statement
Cash Flow Statement
60 Degrees Pharmaceuticals Inc
| Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||
| Net Income |
(12)
|
(4)
|
(4)
|
(1)
|
(2)
|
(8)
|
(8)
|
(10)
|
(8)
|
(8)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
1
|
1
|
4
|
4
|
4
|
4
|
1
|
0
|
|
| Other Non-Cash Items |
5
|
(1)
|
(1)
|
(4)
|
(4)
|
3
|
2
|
4
|
1
|
1
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
5
|
0
|
0
|
(0)
|
(1)
|
1
|
0
|
0
|
0
|
0
|
|
| Cash from Operating Activities |
(2)
N/A
|
(5)
-162%
|
(5)
+0%
|
(5)
-16%
|
(6)
-17%
|
(4)
+34%
|
(6)
-39%
|
(6)
-8%
|
(6)
-4%
|
(7)
-7%
|
|
| Investing Cash Flow | |||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
0
|
0
|
2
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
-32%
|
(0)
-7%
|
(0)
-6%
|
(0)
-92%
|
(2)
-732%
|
(2)
+3%
|
(0)
+91%
|
(0)
+45%
|
2
N/A
|
|
| Financing Cash Flow | |||||||||||
| Net Issuance of Common Stock |
0
|
8
|
8
|
10
|
10
|
4
|
4
|
3
|
3
|
6
|
|
| Net Issuance of Debt |
2
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
3
|
3
|
3
|
3
|
0
|
|
| Cash from Financing Activities |
2
N/A
|
6
+271%
|
6
+1%
|
8
+27%
|
8
-4%
|
7
-10%
|
7
+0%
|
7
-3%
|
7
+0%
|
6
-13%
|
|
| Change in Cash | |||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
|
| Net Change in Cash |
(0)
N/A
|
2
N/A
|
2
+6%
|
3
+53%
|
2
-46%
|
1
-31%
|
(0)
N/A
|
1
N/A
|
0
-30%
|
1
+109%
|
|
| Free Cash Flow | |||||||||||
| Free Cash Flow |
(2)
N/A
|
(5)
-156%
|
(5)
0%
|
(5)
-16%
|
(6)
-18%
|
(4)
+32%
|
(6)
-35%
|
(6)
-8%
|
(6)
-3%
|
(7)
-6%
|
|